The Philadelphia Department of Public Health (PDPH) Division of Disease Control collects, manages and analyzes data on active Tubercolusis (TB) disease, LTBI and other infections caused by mycobacteria related to Mycobacterium tuberculosis. Data collected include, but are not limited to, demographic, diagnostic and surveillance specific disease characteristics such as drug resistance. Accurate identification and timely reporting of both tuberculosis disease and infection are critical to successful treatment of patients and control of the spread of TB infection. Successful TB surveillance allows PDPH to:
  • Provide Directly Observed Therapy (DOT), which is the preferred standard of care for patients with active tuberculosis;
  • Identify contacts who may be infected or at risk of infection to offer preventive therapy;
  • Assist healthcare providers in identifying, evaluating and managing TB patients (through Self Administered Therapy or SAT) and populations at risk for TB infection;
  • Determine the incidence of active disease and the prevalence of latent TB infection in a specific population.

Click here for more information on Tuberculosis, including how and when to report a case and other disease guidance.

Click here to download the latest report of TB activity (posted July 13, 2017) in a printable format.

Tuberculosis Case Counts

Philadelphia TB Case Count, 2005/2016
Philadelphia TB Cases by Race and Ethnicity, 2010/2015
TB Cases By Age Group, 2016
TB Cases in Commonwealth of Pennsylvania, 2016

Foreign Born and US Born Cases

U.S. Born vs. Foreign Born Cases of TB in Philadelphia, 2004/2016
Philadelphia Foreign Born TB Cases by World Health Organization, 2016
Proportion of Drug Resistance in Positive Culture U.S. and Foreign Born Cases with Drug Sensitivity Testing, 2008/2015

Risk Factors and Disease Sites

Sites of Disease, 2015
Percentage of Common Risk Factors Among TB Patients, 2015

Updated: 07/13/2016